{"altmetric_id":13491558,"counts":{"readers":{"mendeley":7,"citeulike":0,"connotea":0},"total":{"posts_count":5},"twitter":{"unique_users_count":3,"unique_users":["BibliotecaHUVH","BVMurciasalud","ONCOTARGETJRNL"],"posts_count":3},"facebook":{"unique_users_count":2,"unique_users":["116510845078689","162255510496328"],"posts_count":2}},"selected_quotes":["Karyotypic complexity rather than chromosome 8 abnormalities aggrav #hvhebron #hemat [Text com\u2026","Karyotypic complexity rather than chromosome 8 abnormalities aggrav #hvhebron #hemat [Text complet] @ONCOTARGETJRNL"],"citation":{"abstract":"Patients with chronic lymphocytic leukemia (CLL) harboring TP53 aberrations (TP53abs; chromosome 17p deletion and\/or TP53 mutation) exhibit an unfavorable clinical outcome. Chromosome 8 abnormalities, namely losses of 8p (8p-) and gains of 8q (8q+) have been suggested to aggravate the outcome of patients with TP53abs. However, the reported series were small, thus hindering definitive conclusions. To gain insight into this issue, we assessed a series of 101 CLL patients harboring TP53 disruption. The frequency of 8p- and 8q+ was 14.7% and 17.8% respectively. Both were associated with a significantly (P < 0.05) higher incidence of a complex karyotype (CK, \u22653 abnormalities) detected by chromosome banding analysis (CBA) compared to cases with normal 8p (N-8p) and 8q (N-8q), respectively. In univariate analysis for 10-year overall survival (OS), 8p- (P = 0.002), 8q+ (P = 0.012) and CK (P = 0.009) were associated with shorter OS. However, in multivariate analysis only CK (HR = 2.47, P = 0.027) maintained independent significance, being associated with a dismal outcome regardless of chromosome 8 abnormalities. In conclusion, our results highlight the association of chromosome 8 abnormalities with CK amongst CLL patients with TP53abs, while also revealing that CK can further aggravate the prognosis of this aggressive subgroup.","altmetric_jid":"4f6fa8213cf058f61000bc6f","authors":["Gonzalo Blanco","Anna Puiggros","Panagiotis Baliakas","Anastasia Athanasiadou","M\u00aaDolores Garc\u00eda-Malo","Rosa Collado","Aliki Xochelli","Mar\u00eda Rodr\u00edguez-Rivera","Margarita Ortega","M\u00aa Jos\u00e9 Calasanz","Elisa Lu\u00f1o","M\u00aaTeresa Vargas","Javier Grau","Carolina Mart\u00ednez-Laperche","Alberto Valiente","Jos\u00e9 Cervera","Achilles Anagnostopoulos","Eva Gimeno","Eug\u00e8nia Abella","Evangelia Stalika","Jes\u00fas M\u00aa Hern\u00e1ndez-Rivas","Francisco Jos\u00e9 Ortu\u00f1o","Diego Robles","Ana Ferrer","David Ivars","Marcos Gonz\u00e1lez","Francesc Bosch","Pau Abrisqueta","Kostas Stamatopoulos","Blanca Espinet","Blanco, Gonzalo","Puiggros, Anna","Baliakas, Panagiotis","Athanasiadou, Anastasia","Garc\u00eda-Malo, M\u00aaDolores","Collado, Rosa","Xochelli, Aliki","Rodr\u00edguez-Rivera, Mar\u00eda","Ortega, Margarita","Calasanz, M\u00aa Jos\u00e9","Lu\u00f1o, Elisa","Vargas, M\u00aaTeresa","Grau, Javier","Mart\u00ednez-Laperche, Carolina","Valiente, Alberto","Cervera, Jos\u00e9","Anagnostopoulos, Achilles","Gimeno, Eva","Abella, Eug\u00e8nia","Stalika, Evangelia","Hern\u00e1ndez-Rivas, Jes\u00fas M\u00aa","Ortu\u00f1o, Francisco Jos\u00e9","Robles, Diego","Ferrer, Ana","Ivars, David","Gonz\u00e1lez, Marcos","Bosch, Francesc","Abrisqueta, Pau","Stamatopoulos, Kostas","Espinet, Blanca"],"doi":"10.18632\/oncotarget.13106","first_seen_on":"2016-11-10T12:13:57+00:00","funders":["niehs"],"issns":["1949-2553"],"journal":"Oncotarget","last_mentioned_on":1478810300,"links":["http:\/\/www.impactjournals.com\/oncotarget\/index.php?journal=oncotarget&page=article&op=view&path[]=13106","https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27821812","http:\/\/www.impactjournals.com\/oncotarget\/index.php?journal=oncotarget&page=article&op=view&path%5B%5D=13106","http:\/\/dx.doi.org\/10.18632\/oncotarget.13106"],"pdf_url":"http:\/\/www.impactjournals.com\/oncotarget\/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=13106&path%5B%5D=41543","pmid":"27821812","pubdate":"2016-11-04T00:00:00+00:00","publisher":"Impact Journals","subjects":["neoplasms"],"title":"Karyotypic complexity rather than chromosome 8 abnormalities aggravates the outcome of chronic lymphocytic leukemia patients with <i>TP53<\/i> aberrations","type":"article","mendeley_url":"http:\/\/www.mendeley.com\/research\/karyotypic-complexity-rather-chromosome-8-abnormalities-aggravates-outcome-chronic-lymphocytic-leuke"},"altmetric_score":{"score":1.5,"score_history":{"1y":1.5,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":1.5},"context_for_score":{"all":{"total_number_of_other_articles":7672691,"mean":6.5915218985731,"rank":3516734,"this_scored_higher_than_pct":51,"this_scored_higher_than":3982850,"rank_type":"exact","sample_size":7672691,"percentile":51},"similar_age_3m":{"total_number_of_other_articles":232033,"mean":12.975741156392,"rank":109719,"this_scored_higher_than_pct":50,"this_scored_higher_than":116264,"rank_type":"exact","sample_size":232033,"percentile":50},"this_journal":{"total_number_of_other_articles":7624,"mean":2.9323064410337,"rank":1560,"this_scored_higher_than_pct":74,"this_scored_higher_than":5692,"rank_type":"exact","sample_size":7624,"percentile":74},"similar_age_this_journal_3m":{"total_number_of_other_articles":886,"mean":5.389218079096,"rank":212,"this_scored_higher_than_pct":73,"this_scored_higher_than":652,"rank_type":"exact","sample_size":886,"percentile":73}}},"demographics":{"poster_types":{"member_of_the_public":1,"practitioner":2},"users":{"twitter":{"cohorts":{"Practitioners (doctors, other healthcare professionals)":2,"Members of the public":1}},"mendeley":{"by_status":{"Librarian":4,"Researcher":2,"Student  > Ph. D. Student":1},"by_discipline":{"Medicine and Dentistry":3,"Agricultural and Biological Sciences":1,"Biochemistry, Genetics and Molecular Biology":1,"Environmental Science":1,"Arts and Humanities":1}}},"geo":{"twitter":{"ES":2,"US":1}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/BibliotecaHUVH\/statuses\/796687283441303553","license":"gnip","citation_ids":[13491558],"posted_on":"2016-11-10T12:13:44+00:00","author":{"name":"BibliotecaHUVH. ICS","url":"http:\/\/www.vhebron.net","image":"https:\/\/pbs.twimg.com\/profile_images\/875677660990636032\/7po0FDW5_normal.jpg","description":"Biblioteca Digital de l\u2019Hospital Universitari Vall d\u2019Hebron. Institut Catal\u00e0 de la Salut. Departament de Salut. Generalitat de Catalunya","id_on_source":"BibliotecaHUVH","tweeter_id":"124130301","geo":{"lt":41.38879,"ln":2.15899,"country":"ES"},"followers":2035},"tweet_id":"796687283441303553"},{"url":"http:\/\/twitter.com\/BVMurciasalud\/statuses\/796770776737345536","license":"gnip","citation_ids":[13491558],"posted_on":"2016-11-10T17:45:31+00:00","author":{"name":"BVirtual Murciasalud","url":"http:\/\/www.murciasalud.es\/bvms","image":"https:\/\/pbs.twimg.com\/profile_images\/489295536244015104\/WBHTnVIf_normal.png","description":"La Biblioteca de la Consejer\u00eda de Sanidad y el SMS para los profesionales sanitarios de la Regi\u00f3n de Murcia. Miembro de @rebisalud","id_on_source":"BVMurciasalud","tweeter_id":"268249666","geo":{"lt":38,"ln":-1.5,"country":"ES"},"followers":1009},"tweet_id":"796770776737345536"},{"url":"http:\/\/twitter.com\/ONCOTARGETJRNL\/statuses\/796814267030896640","license":"gnip","rt":["BibliotecaHUVH"],"citation_ids":[13491558],"posted_on":"2016-11-10T20:38:20+00:00","author":{"name":"Oncotarget","url":"http:\/\/www.oncotarget.com","image":"https:\/\/pbs.twimg.com\/profile_images\/910251053291048961\/YLi4V6W6_normal.jpg","description":"#Scholarly #Medical #Journal","id_on_source":"ONCOTARGETJRNL","tweeter_id":"702864980362702849","geo":{"lt":42.76756,"ln":-78.74392,"country":"US"},"followers":1623},"tweet_id":"796814267030896640"}],"facebook":[{"title":"Karyotypic complexity rather than chromosome 8 abnormalities aggravates the outcome of chronic lymphocytic leukemia patients with TP53 aberrations","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=1244357495627346&id=116510845078689","license":"public","citation_ids":[13491558],"posted_on":"2016-11-10T12:13:53+00:00","summary":"Karyotypic complexity rather than chromosome 8 abnormalities aggrav  https:\/\/t.co\/SBvlgFS1tm #hvhebron #hemat [Text complet] @ONCOTARGETJRNL","author":{"name":"Biblioteca Digital de l'Hospital Universitari Vall d'Hebron. ICS","url":"https:\/\/www.facebook.com\/116510845078689","facebook_wall_name":"Biblioteca Digital de l'Hospital Universitari Vall d'Hebron. ICS","image":"https:\/\/graph.facebook.com\/116510845078689\/picture","id_on_source":"116510845078689"}},{"title":"Karyotypic complexity rather than chromosome 8 abnormalities aggravates the outcome of chronic lymphocytic leukemia patients with TP53 aberrations. - PubMed - NCBI","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=1154285727959963&id=162255510496328","license":"public","citation_ids":[13491558,13491558],"posted_on":"2016-11-10T13:06:40+00:00","summary":"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27821812","author":{"name":"BVMS: Biblioteca Virtual Murciasalud","url":"https:\/\/www.facebook.com\/162255510496328","facebook_wall_name":"BVMS: Biblioteca Virtual Murciasalud","image":"https:\/\/graph.facebook.com\/162255510496328\/picture","id_on_source":"162255510496328"}}]}}